Attorneys Oded Har-Even and Howard Berkenbilt from our U.S. Capital Markets department, represented the company in it's acquisition by Francisco Partners L.P in an amount of $438 million.
May, 2015
.jpg?w=300 "IATI’s forum of public biomed companies")
Adv. Oded Har-Even (third from the right), the managing partner of the firm’s U.S. offices, participated in a meeting of executives from public biomed companies. The participants discussed ways to increase investment by Israeli institutional bodies – banks, insurance companies and private investors, in biomed companies.
Globes, July 21, 2016
This week IAC NY held A Breakfast with Israel’s Ambassador to the United Nations Danny Danon. Over 150 guests listened to the Ambassador provide an in-depth analysis of the challenges, and opportunities, facing Israel and the daily activities of Israel’s Mission to the UN. The entire event was planned and sponsored by IAC Council Member. (Photographer, Idan Siman Tov).
Ynet, 6.5.16
Attorneys Oded Har Even, Howard Berkenblit and David Huberman represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.
May, 2016
On November 31, 2015, our firm hosted a festive cocktail in collaboration with the investment bank Aegis Capital Corp, bringing together senior bankers and private companies that raised more than 10 million dollars, in addition to public companies.
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
July, 2016
On 9.11.2016 we held a conference together with ACC Israel. Adv. Andrew Solomon, a partner in the litigation department in our offices in New York, Oded Har-Even, director of the US offices and Shay Baranov, director of the international department at our offices in Tel Aviv, Lectured about the various issues faced by companies seeking to expand their operations in the U.S.
The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company’s board of directors, as well as other existing shareholders.
February, 2016
Attornyes Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer's counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.
March, 2016
Attorneys Oded Har-Even, Rob Condon and Hila Nahum represented the Bank on a public offdering of VistaGen Therapeutics, a biomed company that develops products for the treatment of diseases related to the nervous system.
May, 2016
.jpg?w=300 "ZAG-S&W represented Aegis Capital Corp. in a $10 Million public offering of common stock, warrants and convertible preferred stock for Rennova Health Inc.")
Aegis Capital Corp. is an investment bank and underwriter. Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market.
December, 2015
Attorneys Oded Har-Even, Shy Baranov, Rob Condon, David Huberman and Ron Ben-Bassat, represented Renshaw & Rodman.
June, 2016
Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.
July, 2016
.jpg?w=300 "The firm represented the US investment bank Gunner & Joseph in a public offering of Rennova Health.")
Attorneys Oded Har-Even, Rob Condon, Hila Nahum, Jene Schlack and Ron Ben-Bassat, represented Gunner & Joseph who served as an underwriter in the offering.
July, 2016
The team includud Oded Har-Even, Robert Condon, Ron Ben Bassat and Leigh Sapir-Kashi. Roth Capital Partners acted as the lead placement agent and Maxim Group LLC acted as the co-placement agent for this transaction.
September, 2016
Attorrneys Oded Har-Even and Robert Condon at the annual conference.
12.9.2016
.jpg?w=300 "ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million")
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
September, 2016
ZAG-S&W and Oded Har-Even were featured in the article which discusses two U.S. law firms, including ZAG-S&W, that work extensively with Israeli companies
LAW.COM, 10.10.16
.jpg?w=300 "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics")
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.
December, 2016
.jpg?w=300 "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.")
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $12.4 million private placement offering of preferred shares By Rennova Health Inc.
December, 2016
.jpg?w=300 "ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.")
Attornyes Oded Har-Even, Rob Condon and Hila Nahum represented Roth Capital.
December, 2016
.jpg?w=300 "ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment")
Attorney Oded Har-Even represented Roth Capital in a $5 million private placement of Top Image System.
December, 2016
.jpg?w=300 "ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million")
Attornyes Oded Har-Even, Ron Ben-Bassat and Robert Condon represented DarioHealth Corp. in the private placement.
The deal was led by OurCrowd Qure, a dedicated digital health fund.
January, 2017
Advs. Oded Har-Even, Rob Condon and Ron Ben-Bassat from the American Capital Markets departmemt at the firm represented the company in a private placement on Nasdaq
Globes, 15.1.2017
